Major therapeutic targets for the management of cardiovascular disorder in T2DM patient. Abbreviations: ANG II, Angiotensin II; FFA, free fatty acid; HDL, high density lipoprotein; LDL, low density lipoprotein; NO, nitric oxide; T2DM, Type 2 diabetes mellitus.